Announcements
Announcement on behalf of Amaran of important resolutions of the 2023 annual shareholders’ meeting
1.Date of the shareholders’ meeting: 2023/06/20 2.Important resolutions I. Profit distribution/deficit compensation: Acknowledgement of the 2022 Earning Distribution Loss Off-setting. 3.Important resolutions II. Amendments of the company charter: Resolution of …
Announcement on behalf of Obigen’s resolution to lift the non-competition restrictions for directors at 2023 annual shareholders’ meeting
1.Date of the shareholders’ meeting resolution:2023/06/16 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director Frank Chen, Representative of OBI Pharma, Inc. Director Chung …
Announcement on behalf of Obigen of important resolutions of the 2023 annual shareholders’ meeting
1.Date of the shareholders’ meeting:2023/06/16 2.Important resolutions I. Profit distribution/deficit compensation: Acknowledgement of the 2022 Earning Distribution Loss Off-setting. 3.Important resolutions II. Amendments of the company charter: None 4.Important resolutions …
The COVID-19 vaccine, BCVax, has been granted by TFDA to proceed to Phase I clinical trial
1.Date of occurrence of the event:2023/06/02 2.New drug name or code:COVID-19 vaccine, BCVax 3.Indication: COVID-19 vaccine, BCVax, is composed of the Delta spike protein with nanoparticle saponins as adjuvant that …
Announcement of change Spokesperson
1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development …
Announcement of change of CEO
1.Date of the board of directors resolution or date of occurrence of the change: 2023/06/02 2.Position (Please enter chairperson or president/general manager): CEO 3.Name of the previous position holder: Yun …
Announcement on behalf of Obigen that the BOD resolved to issue 2023 employee stock options and the subscription rules.
1.Date of the board of directors resolution:2023/05/26 2.Issue period: Issued within two years since the date of approval of Board of Directors; issued at once or in tranches depending on …
Announcement on behalf of Obigen to change its financial and accounting officer
1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development …
The Company’s BOD resolved to amend the plan to disperse shareholding of Obigen (New Shareholding Dispersal Method)
1.Date of occurrence of the event:2023/05/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: N/A 5.Cause of occurrence: To …
The Company’s BOD resolved to amend the plan to disperse shareholding of AP Biosciences (New Shareholding Dispersal Method)
1.Date of occurrence of the event:2023/05/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: N/A 5.Cause of occurrence: To …